ACHE and Alzheimer disease: In between IV infusions, AD patients taking these biologics would benefit from digital interventions delivering non-pharmacological treatments, similar to those AD patients who received NMDA antagonists, acetylcholine esterase inhibitors, and internet-delivered multimodal treatments [58].